Senior insider sale
CFO AND TREASURER at UNITED THERAPEUTICS CORP — senior position signals high conviction
$152.83M
268.75K shares
EDGEMOND JAMES plans to sell 268.75K shares of UNITED THERAPEUTICS CORP valued at approximately $152.83M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Stock Options
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Exercise of Stock Options Cash | 148.75K | — |
| Total | 148.75K | ||
Completed
Units to sell
10K
Market value
$5.73M
Units to sell
10K
Market value
$5.69M
Units to sell
10K
Market value
$5.72M
Units to sell
10K
Market value
$5.78M
Units to sell
10K
Market value
$5.77M
Units to sell
10K
Market value
$5.75M
Units to sell
10K
Market value
$5.78M
Units to sell
10K
Market value
$5.58M
Units to sell
10K
Market value
$5.61M
Units to sell
10K
Market value
$5.93M
Units to sell
10K
Market value
$5.36M
Units to sell
10K
Market value
$5.27M
Planned — Approximate Date
Units to sell
148.75K
Market value
$84.85M
Units
268.75K
Value
$152.83M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/30/2026 | 10K | $5.73M | — | Completed |
4/27/2026 | 10K | $5.69M | — | Completed |
4/23/2026 | 10K | $5.72M | — | Completed |
4/20/2026 | 10K | $5.78M | — | Completed |
4/16/2026 | 10K | $5.77M | — | Completed |
4/13/2026 | 10K | $5.75M | — | Completed |
4/9/2026 | 10K | $5.78M | — | Completed |
4/6/2026 | 10K | $5.58M | — | Completed |
4/2/2026 | 10K | $5.61M | — | Completed |
3/30/2026 | 10K | $5.93M | — | Completed |
3/26/2026 | 10K | $5.36M | — | Completed |
3/23/2026 | 10K | $5.27M | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 148.75K | $84.85M | NASDAQ | Planned |
| Total | 268.75K | $152.83M | ||